Viewing Study NCT00117351


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-25 @ 9:31 PM
Study NCT ID: NCT00117351
Status: TERMINATED
Last Update Posted: 2011-02-17
First Post: 2005-06-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module